Lantibiotics: promising candidates for future applications in health care.
about
Lanthipeptides: chemical synthesis versus in vivo biosynthesis as tools for pharmaceutical productionBioengineering Lantibiotics for Therapeutic SuccessBioengineering of the model lantibiotic nisinProspects of In vivo Incorporation of Non-canonical Amino Acids for the Chemical Diversification of Antimicrobial PeptidesThe Solution Structure of the Lantibiotic Immunity Protein NisI and Its Interactions with Nisin.The Bacillus cereus group is an excellent reservoir of novel lanthipeptides.Pseudomycoicidin, a Class II Lantibiotic from Bacillus pseudomycoides.Expanded natural product diversity revealed by analysis of lanthipeptide-like gene clusters in actinobacteriaStructure of the Response Regulator NsrR from Streptococcus agalactiae, Which Is Involved in Lantibiotic Resistance.Three Novel Lantibiotics, Ticins A1, A3, and A4, Have Extremely Stable Properties and Are Promising Food Biopreservatives.Thusin, a Novel Two-Component Lantibiotic with Potent Antimicrobial Activity against Several Gram-Positive PathogensOne-pot synthesis of class II lanthipeptide bovicin HJ50 via an engineered lanthipeptide synthetase.Strategies for the use of bacteriocins in Gram-negative bacteria: relevance in food microbiologyAdvancing cell wall inhibitors towards clinical applications.Chemical and Biological Aspects of Nutritional Immunity - Perspectives for New Anti-infectives Targeting Iron Uptake Systems.Employing the promiscuity of lantibiotic biosynthetic machineries to produce novel antimicrobials.Surface and Exoproteomes of Gram-Positive Pathogens for Vaccine Discovery.Pharmacological and pharmacokinetic properties of lanthipeptides undergoing clinical studies.Identification of the Biosynthesis Gene Cluster for the Novel Lantibiotic Paenilan from Paenibacillus polymyxa E681 and Characterization of its Product.Incorporation of tryptophan analogues into the lantibiotic nisin.Lantibiotic Reductase LtnJ Substrate Selectivity Assessed with a Collection of Nisin Derivatives as Substrates.Antibacterial activity of the novel semisynthetic lantibiotic NVB333 in vitro and in experimental infection models.Pinensins: the first antifungal lantibiotics.Structural basis of lantibiotic recognition by the nisin resistance protein from Streptococcus agalactiae.The N-terminal Region of Nisin Is Important for the BceAB-Type ABC Transporter NsrFP from Streptococcus agalactiae COH1.High Throughput Identification of Antimicrobial Peptides from Fish Gastrointestinal Microbiota.Lactococcus lactis LMG2081 Produces Two Bacteriocins, a Nonlantibiotic and a Novel Lantibiotic.Genome analysis reveals insights of the endophytic Bacillus toyonensis BAC3151 as a potentially novel agent for biocontrol of plant pathogens.Phage display and selection of lanthipeptides on the carboxy-terminus of the gene-3 minor coat protein.EMA and EFSA Joint Scientific Opinion on measures to reduce the need to use antimicrobial agents in animal husbandry in the European Union, and the resulting impacts on food safety (RONAFA)CerR, a Single-domain Regulatory Protein of the LuxR Family, Promotes the Cerecidin Production and Immunity in Bacillus cereus.Major gene-regulatory mechanisms operating in ribosomally synthesized and post-translationally modified peptide (RiPP) biosynthesis.Stress enhances the sensitivity of Salmonella enterica serovar Typhimurium to bacteriocins.Discovery of a novel lantibiotic nisin O from Blautia obeum A2-162, isolated from the human gastrointestinal tract.Differences in the antibacterial activity of nisin and bovicin HC5 against Salmonella Typhimurium under different temperature and pH conditions.Carboxyl Analogue of Mutacin 1140, a Scaffold for Lead Antibacterial Discovery.Expanding the Genetic Code of Lactococcus lactis and Escherichia coli to Incorporate Non-canonical Amino Acids for Production of Modified Lantibiotics.Perspectives on lantibiotic discovery - where have we failed and what improvements are required?Mutagenicity comparison of nine bioselenocompounds in three Salmonella typhimurium strains.Processing and Structure of the Lantibiotic Peptide Nso From the Human Gut Bacterium Blautia obeum A2-162 analysed by Mass Spectrometry.
P2860
Q26748638-4C622314-ECF5-4BD8-B681-3D5576128675Q26774123-C007BA61-D318-4C61-AB49-0F746BD9550CQ28087616-45397512-10AC-4D48-9FC6-BA0BDC2E2738Q28817674-F34291C8-C4CB-433D-BD6F-93D548B41911Q30380211-CE2C7EFF-D431-490E-A8DE-B7692E5ADC72Q35075125-495DDFBB-AA75-47DC-86D7-B223D3A0FABDQ35529780-7032FEF7-43E3-4C3D-8AEA-43048ACEDFE0Q35764125-C608E88B-B4D8-4906-A6FA-A2E563A64BC3Q35940689-494787A7-761E-4D1F-A6E5-3107FDC291CFQ36084554-D619849F-83DD-42CF-99B1-EDCD7FCAB74EQ37106265-A3588628-A068-457F-82C0-75F1A67B6FD3Q37480151-CA0531F2-B6F0-43ED-9C43-F8A28228265CQ38582177-C69B8162-C56B-4C95-AD46-C5CC8E1DCBD6Q38620000-BAD41BC9-3972-487A-BFBE-46169FCB7F67Q38691254-8378278D-0974-49A9-8E26-32DADEFA00ECQ38945513-967F47A2-D800-41E4-A02D-25B08AB00B74Q38958617-0EC4E3EF-7D9B-4836-9D11-979183317473Q39065285-67242EC0-8D96-4509-A92B-C8F2F1B417C5Q40067898-C23D9F6F-B2D0-408A-8FB6-CB54A9DCBEDFQ40247528-66A65391-756C-4FED-AF62-23031997DDEAQ40316133-40EC965A-A0EA-4C5B-96A8-1844D239E904Q40670947-C85BB78B-8516-4D44-A83E-2CBFB4A5974FQ40695785-56707280-D29B-4FC2-A8C1-4D310267A424Q41353941-515CB417-B3FC-43CB-ADE4-DA871ED52013Q41608608-A86DC33E-C349-492A-947D-F25A6B1B0494Q41669320-19CB52DA-DCCF-484D-852B-27077846F6FAQ42406555-97D7DC66-0757-4E04-8C57-1BEA41665FA6Q46300601-29005001-7554-4633-AF9B-D132E0409A42Q47134907-D8B0D441-69FD-4B95-A0AF-2F3E16A14785Q47158624-6C01D5EC-0E24-4E7D-8F74-563D0421EFD5Q47244740-28F7191E-584D-498E-A520-AB0D6D6EB401Q47978511-E83E739E-288B-4644-896D-D502B13541B4Q49990543-116C0325-EE3B-4BCE-AC01-CA61DBC819E0Q50251400-51516909-BE42-47DC-A9F5-FC15FECBDEB6Q50424919-D8CDB852-D17C-4FD2-860B-38E28BEFC75AQ51005035-5EBA2DEA-4AE1-4DA8-819D-AC2076336806Q52571435-E5A8AA65-EB5C-43F9-83D7-218A527DBB55Q53603656-9316B50B-AEF0-4DB1-8B34-BE62A3C35F1CQ54940560-50113EAC-BFB3-4BC6-86DA-99DD40CAA24EQ55650113-B1F49B34-928D-4FBC-8714-40F357C37B03
P2860
Lantibiotics: promising candidates for future applications in health care.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Lantibiotics: promising candidates for future applications in health care.
@en
type
label
Lantibiotics: promising candidates for future applications in health care.
@en
prefLabel
Lantibiotics: promising candidates for future applications in health care.
@en
P2093
P1476
Lantibiotics: promising candidates for future applications in health care.
@en
P2093
Gabriele Bierbaum
Jasmin Dischinger
Shradha Basi Chipalu
P356
10.1016/J.IJMM.2013.09.003
P577
2013-09-04T00:00:00Z